NDC 12822-0313

ANNOVERA

Segesterone Acetate, Ethinyl Estradiol

ANNOVERA is a Vaginal Ring in the Human Prescription Drug category. It is labeled and distributed by Qpharma Ab. The primary component is Segesterone Acetate; Ethinyl Estradiol.

Product ID12822-0313_90b50883-bb8c-47a1-e053-2995a90a1651
NDC12822-0313
Product TypeHuman Prescription Drug
Proprietary NameANNOVERA
Generic NameSegesterone Acetate, Ethinyl Estradiol
Dosage FormRing
Route of AdministrationVAGINAL
Marketing Start Date2019-08-08
Marketing CategoryNDA / NDA
Application NumberNDA209627
Labeler NameQPharma AB
Substance NameSEGESTERONE ACETATE; ETHINYL ESTRADIOL
Active Ingredient Strength103 mg/1; mg/1
Pharm ClassesEstrogen Receptor Agonists [MoA],Estrogen [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 12822-0313-1

1 POUCH in 1 CARTON (12822-0313-1) > 1 RING in 1 POUCH
Marketing Start Date2019-08-08
NDC Exclude FlagN
Sample Package?N

Drug Details

Active Ingredients

IngredientStrength
SEGESTERONE ACETATE103 mg/1

OpenFDA Data

SPL SET ID:82dacbf8-5267-4c7f-bf1a-f5c755f64619
Manufacturer
UNII
UPC Code
  • 0350261313013
  • Pharmacological Class

    • Estrogen Receptor Agonists [MoA]
    • Estrogen [EPC]

    NDC Crossover Matching brand name "ANNOVERA" or generic name "Segesterone Acetate, Ethinyl Estradiol"

    NDCBrand NameGeneric Name
    12822-0313ANNOVERASEGESTERONE ACETATE, ETHINYL ESTRADIOL
    50261-313ANNOVERAsegesterone acetate and ethinyl estradiol

    Trademark Results [ANNOVERA]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    ANNOVERA
    ANNOVERA
    87849469 not registered Live/Pending
    The Population Council, Inc.
    2018-03-26

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.